IP Library Granted Patent US 11,224,850
Granted Patent B2
US 11,224,850 · App. 16/795,970 · Granted Jan 18, 2022

Regulated multiplex reactions in a single tube

Inventors: Anthony P. Shuber (Northbridge, MA); William Glover (Wakefield, MA)
Assignee: GENETICS RESEARCH, LLC
B01J19/0046C12N9/0022C12N9/22C12N15/11C12N15/113C12Q1/34C12Q1/48C12Q1/6806C12Q1/6848C12N2310/20C12N2800/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,224,850
App. No.
16/795,970
Granted
Jan 18, 2022
Kind
B2
Abstract

The invention provided methods and devices for performing sequential, regulated multiplex reactions in a single tube without the addition or removal of contents from the tube.

Claims (15)

1. A reaction system comprising:

a single reaction compartment comprising:

a first set of reaction components comprising Cas endonuclease proteins and guide RNAs that together form a complex that target sequences that flank a target nucleic acid, thereby protecting the target nucleic acid, if present in the compartment, from exonuclease digestion and an exonuclease,

wherein the first set of reaction components are active at a first temperature and inactive at a second higher temperature; and

a second set of reaction components comprising primers and a thermostable polymerase active at the second temperature and inactive at the first temperature, wherein the first and second set of reaction components may be independently activated and/or deactivated by a change in the temperature of the compartment.

2. The system of claim 1 , wherein the compartment comprises a sample tube.

3. The system of claim 1 , wherein the first and second set of reaction components are packaged together within a sample tube.

4. The system of claim 1 , wherein when a sample comprising target nucleic acid and non-target nucleic acid is added to the reaction compartment and heated to the first temperature, the first set of reaction components digests the non-target nucleic acid, and when the reaction compartment is heated to a second temperature, the second set of reaction components synthesizes a copy of the target nucleic acid.

5. The system of claim 1 , wherein, when a sample comprising target nucleic acid and non-target nucleic acid is added to the reaction compartment, the reaction compartment may be sealed and brought to a first temperature at which the first set of reaction components degrades the non-target nucleic acid and protects the target nucleic acid and then the reaction compartment may, without unsealing the reaction compartment, be brought to a second temperature at which the second set of reaction components synthesizes a copy of the target nucleic acid.

6. The system of claim 1 , wherein the Cas endonuclease proteins are complexed with the guide RNAs as ribonucleoproteins and the primers include phosphorothioate linkages rendering the primers resistant to digestion by the exonuclease.

7. The system of claim 1 , wherein the first set of reaction components and the second set of reaction components are pre-packaged into the reaction compartment, and the reaction compartment is a sample tube or a well of a multi-well plate.

8. The system of claim 1 , wherein the reaction compartment is provided as a sample tube or a well of a multi-well plate containing therein the first and second set of reaction components, each present in the form of one or more beads or particles, wherein the first set of reaction components includes: at least one active or catalytically-inactive Cas endonuclease complexed with a guide RNA that targets the Cas endonuclease to sequences that flank a target nucleic acid, and exonuclease; and the second set of reaction components includes:

at least one exonuclease resistant primer that hybridizes to the target nucleic acid and polymerase.

9. The system of claim 8 , wherein the first set of reaction components is active between about 30 and 45 degrees C. and the second set of reaction components is active between about 80 and 105 degrees C.

10. The system of claim 8 , wherein the first and second set of reaction components are present as lyophilized particles or provided by hydrogel beads.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2023
From: GENETICS RESEARCH, LLC, D/B/A ZS GENETICS, INC.
To: HARBINGER HEALTH, INC.
Reel/Frame 065568/0557 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2020
From: SHUBER, ANTHONY P.; GLOVER, WILLIAM
To: GENETICS RESEARCH, LLC D/B/A ZS GENETICS, INC.
Reel/Frame 052682/0518 →
Continuity (2)
Provisional Application 62808033 · Feb 20, 2019
Related Publication 20200261881A1 · Aug 20, 2020